Header Logo

James Mulshine

Concepts (641)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
160
2023
509
16.290
Why?
Tomography, X-Ray Computed
30
2021
698
4.650
Why?
Mass Screening
32
2023
168
4.400
Why?
Early Detection of Cancer
14
2023
90
3.450
Why?
Carcinoma, Non-Small-Cell Lung
40
2016
228
2.490
Why?
Tomography, Spiral Computed
15
2014
25
2.040
Why?
Carcinoma, Small Cell
42
2005
50
1.990
Why?
Biomarkers, Tumor
28
2010
184
1.800
Why?
Pulmonary Disease, Chronic Obstructive
3
2021
45
1.710
Why?
Humans
188
2023
25692
1.530
Why?
Antibodies, Monoclonal
38
1999
185
1.440
Why?
Smoking
14
2015
165
1.170
Why?
Emphysema
2
2023
4
1.070
Why?
Drug Design
6
2013
23
1.050
Why?
Multiple Pulmonary Nodules
2
2014
12
0.940
Why?
Peptides
20
1997
104
0.870
Why?
Pulmonary Emphysema
1
2023
2
0.860
Why?
Neoplasms
10
2014
224
0.850
Why?
Tumor Cells, Cultured
39
2005
110
0.850
Why?
Anticarcinogenic Agents
8
2005
16
0.800
Why?
Neoplasm Proteins
8
2007
45
0.780
Why?
Drug Delivery Systems
5
2009
29
0.750
Why?
Breast Neoplasms
11
2015
369
0.740
Why?
Gene Expression Regulation, Neoplastic
7
2010
92
0.720
Why?
Lung
10
2023
159
0.700
Why?
Growth Substances
13
1996
29
0.700
Why?
Sputum
14
2005
20
0.680
Why?
Cell Transformation, Neoplastic
6
2003
29
0.660
Why?
Occupational Exposure
2
2018
16
0.630
Why?
Systems Biology
1
2018
5
0.630
Why?
Antineoplastic Agents
9
2016
169
0.620
Why?
Radiation Exposure
1
2018
9
0.620
Why?
Neoplasms, Radiation-Induced
1
2018
11
0.620
Why?
Tobacco Use Disorder
1
2018
16
0.620
Why?
Occupational Diseases
1
2018
20
0.610
Why?
Myocardial Ischemia
1
2018
37
0.600
Why?
Algorithms
4
2015
347
0.590
Why?
Lipoxygenase Inhibitors
5
2001
6
0.580
Why?
Radiographic Image Enhancement
2
2015
27
0.570
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
8
2003
8
0.550
Why?
United States
15
2018
1943
0.540
Why?
Thoracic Surgery, Video-Assisted
2
2015
21
0.540
Why?
Cell Division
21
2003
79
0.530
Why?
Sensitivity and Specificity
13
2016
472
0.520
Why?
DNA-Binding Proteins
8
2003
249
0.510
Why?
Genes, ras
8
2003
13
0.510
Why?
Imaging, Three-Dimensional
2
2014
217
0.510
Why?
Gastrin-Releasing Peptide
18
1999
18
0.500
Why?
Actuarial Analysis
3
2012
8
0.500
Why?
Solitary Pulmonary Nodule
1
2015
14
0.490
Why?
Pneumonectomy
2
2015
76
0.480
Why?
Cyclooxygenase Inhibitors
4
2004
27
0.470
Why?
Publishing
1
2014
38
0.460
Why?
Image Processing, Computer-Assisted
2
2014
163
0.450
Why?
Growth Inhibitors
6
1999
11
0.450
Why?
Smoking Cessation
5
2014
41
0.450
Why?
Carcinoma, Squamous Cell
5
2013
154
0.440
Why?
Genome, Human
1
2013
36
0.430
Why?
Arachidonic Acid
4
2001
14
0.430
Why?
Female
43
2018
14273
0.420
Why?
Inflammation
3
2009
261
0.420
Why?
Diagnostic Imaging
3
2010
66
0.410
Why?
Bronchoalveolar Lavage Fluid
4
1997
14
0.410
Why?
Radiation Dosage
8
2017
35
0.410
Why?
Image Interpretation, Computer-Assisted
3
2009
67
0.410
Why?
Prostaglandin-Endoperoxide Synthases
4
2003
23
0.400
Why?
Insurance Benefits
1
2012
1
0.400
Why?
Oligonucleotide Array Sequence Analysis
3
2007
52
0.400
Why?
Oropharyngeal Neoplasms
2
2004
19
0.400
Why?
Neoplasm Staging
14
2008
315
0.390
Why?
Cost Savings
1
2012
36
0.390
Why?
Mesoderm
2
2010
18
0.390
Why?
Animals
32
2010
3510
0.380
Why?
Heterogeneous-Nuclear Ribonucleoproteins
2
2009
2
0.380
Why?
Male
36
2018
13917
0.370
Why?
Bombesin
9
1997
9
0.370
Why?
Transcription Factors
2
2003
158
0.370
Why?
Epithelium
3
2010
26
0.370
Why?
Reproducibility of Results
8
2016
646
0.370
Why?
Medical Oncology
4
2014
35
0.360
Why?
Precancerous Conditions
5
2004
23
0.360
Why?
Spirometry
1
2010
11
0.350
Why?
Diagnosis, Computer-Assisted
1
2010
16
0.350
Why?
Proportional Hazards Models
4
2010
332
0.340
Why?
Hyaluronic Acid
1
2010
51
0.340
Why?
Intercellular Signaling Peptides and Proteins
1
2010
52
0.340
Why?
Gene Expression Profiling
2
2007
128
0.330
Why?
Chemokines
1
2009
20
0.330
Why?
Cost-Benefit Analysis
5
2014
124
0.320
Why?
Inflammation Mediators
1
2009
65
0.310
Why?
Cytokines
1
2010
212
0.310
Why?
Arachidonate 5-Lipoxygenase
2
1999
4
0.290
Why?
Drug Approval
1
2007
7
0.290
Why?
Middle Aged
27
2018
8403
0.290
Why?
Immunohistochemistry
11
2005
341
0.280
Why?
Retinoids
2
2005
5
0.280
Why?
RNA, Messenger
12
2003
284
0.280
Why?
Isotretinoin
4
2000
6
0.280
Why?
Risk Assessment
7
2014
618
0.280
Why?
Indium Radioisotopes
4
1999
5
0.280
Why?
Ketorolac
2
2004
12
0.270
Why?
Chemoprevention
2
2003
4
0.260
Why?
Radiographic Image Interpretation, Computer-Assisted
4
2017
29
0.260
Why?
Mice
19
2000
1345
0.260
Why?
Practice Guidelines as Topic
4
2014
284
0.260
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2004
100
0.260
Why?
Clinical Trials as Topic
9
2006
209
0.250
Why?
Head and Neck Neoplasms
2
2005
146
0.250
Why?
DNA Mutational Analysis
2
2003
53
0.240
Why?
Risk Factors
11
2012
2224
0.240
Why?
Epithelial Cells
4
2005
72
0.240
Why?
Leukoplakia, Oral
1
2004
2
0.230
Why?
Signal Transduction
5
2001
410
0.230
Why?
Antigens, Neoplasm
9
1994
37
0.230
Why?
Transferrin
3
1996
6
0.230
Why?
Mass Chest X-Ray
1
2003
1
0.220
Why?
Insulin-Like Growth Factor I
8
2001
52
0.220
Why?
Carrier Proteins
3
1999
96
0.220
Why?
Prognosis
10
2005
739
0.210
Why?
Cell Hypoxia
1
2003
11
0.210
Why?
Isoenzymes
3
2000
51
0.210
Why?
Apoptosis
2
2001
177
0.210
Why?
Proto-Oncogene Proteins p21(ras)
1
2003
20
0.210
Why?
Neoplasm Invasiveness
4
2010
75
0.210
Why?
Down-Regulation
1
2003
94
0.200
Why?
Survival Rate
6
2016
308
0.200
Why?
Thoracic Surgical Procedures
2
2012
9
0.200
Why?
Biomarkers
6
2015
554
0.190
Why?
Quality Assurance, Health Care
2
2017
33
0.190
Why?
Hydroxyeicosatetraenoic Acids
1
2001
1
0.190
Why?
Receptors, Cytoplasmic and Nuclear
1
2001
21
0.190
Why?
Neoplasms, Second Primary
3
1997
37
0.190
Why?
Smoking Prevention
3
2013
16
0.180
Why?
Adenocarcinoma
6
1998
132
0.180
Why?
Ribonucleoproteins, Small Nuclear
1
2000
2
0.180
Why?
Disease Management
1
2001
97
0.180
Why?
Membrane Proteins
2
1999
151
0.180
Why?
Software
2
2014
63
0.180
Why?
Carcinoma
2
1999
63
0.180
Why?
Databases, Factual
2
2006
329
0.170
Why?
National Institutes of Health (U.S.)
3
1996
20
0.170
Why?
Interleukin-6
1
2000
74
0.170
Why?
Aged
19
2018
8501
0.170
Why?
Radioimmunodetection
1
1999
1
0.170
Why?
Polymerase Chain Reaction
8
2003
111
0.170
Why?
Multienzyme Complexes
3
1999
27
0.170
Why?
Advisory Committees
3
2014
19
0.160
Why?
Molecular Sequence Data
14
1996
169
0.160
Why?
Nuclear Weapons
1
2018
1
0.160
Why?
Gene Expression Regulation, Developmental
1
1998
34
0.160
Why?
Genetic Markers
2
2000
36
0.150
Why?
Pancreatic Neoplasms
2
1993
89
0.150
Why?
Receptors, Transferrin
2
1996
4
0.150
Why?
Retinoblastoma Protein
2
1995
10
0.150
Why?
Randomized Controlled Trials as Topic
3
2005
311
0.150
Why?
Thoracic Neoplasms
2
2017
8
0.150
Why?
Microscopy
1
1997
10
0.140
Why?
Lymphoma
4
1991
30
0.140
Why?
Adult
15
2018
7336
0.140
Why?
Point Mutation
1
1997
25
0.140
Why?
Gallium
1
1996
2
0.130
Why?
Biological Specimen Banks
1
1996
8
0.130
Why?
Military Medicine
1
1996
8
0.130
Why?
Mice, Inbred BALB C
6
2000
98
0.120
Why?
Protein Processing, Post-Translational
5
1993
36
0.120
Why?
Indoles
3
2001
35
0.120
Why?
Vascular Calcification
1
2015
9
0.120
Why?
Radioimmunoassay
5
1993
16
0.120
Why?
Coronary Vessels
1
2015
33
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2006
222
0.120
Why?
Base Sequence
7
2003
90
0.120
Why?
Blotting, Northern
5
2003
20
0.120
Why?
Health Policy
1
2015
42
0.120
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2005
12
0.120
Why?
Skin Neoplasms
3
1991
66
0.120
Why?
Mutation
5
2016
325
0.120
Why?
Mice, Nude
8
1998
22
0.120
Why?
Mesothelioma
1
1994
13
0.120
Why?
Physicians, Primary Care
1
2014
7
0.120
Why?
Physician's Role
1
2014
17
0.120
Why?
Electronic Nicotine Delivery Systems
1
2014
2
0.110
Why?
Nuclear Proteins
3
2003
80
0.110
Why?
International Agencies
1
2014
3
0.110
Why?
Amino Acid Sequence
10
1996
137
0.110
Why?
Lymph Nodes
4
1991
66
0.110
Why?
Tobacco Use Cessation
1
2013
1
0.110
Why?
Congresses as Topic
1
2013
30
0.110
Why?
Neoplasm Metastasis
2
2004
91
0.110
Why?
DNA Primers
4
2003
46
0.110
Why?
Evidence-Based Medicine
1
2014
170
0.110
Why?
Incidence
3
2010
731
0.110
Why?
ErbB Receptors
2
2010
52
0.110
Why?
Radiography, Thoracic
2
2005
25
0.100
Why?
Neuropeptides
2
1995
24
0.100
Why?
Genes, Tumor Suppressor
3
2000
8
0.100
Why?
Eicosanoids
2
2003
2
0.100
Why?
Codon
4
2003
5
0.100
Why?
Patient Education as Topic
2
2005
140
0.100
Why?
Drug Screening Assays, Antitumor
4
1999
10
0.100
Why?
Oncogenes
5
1993
9
0.100
Why?
Protein Binding
2
2009
116
0.100
Why?
Research
1
1992
38
0.100
Why?
Receptors, Retinoic Acid
3
2000
3
0.100
Why?
Immunoenzyme Techniques
6
1998
29
0.100
Why?
Dose-Response Relationship, Drug
6
2000
325
0.090
Why?
Microsatellite Repeats
2
2001
9
0.090
Why?
Combined Modality Therapy
7
2016
281
0.090
Why?
Aerosols
2
2002
22
0.090
Why?
Organoplatinum Compounds
1
1990
1
0.090
Why?
Matrix Metalloproteinase 2
1
2010
3
0.090
Why?
Spain
1
2010
7
0.090
Why?
Matrix Metalloproteinase 9
1
2010
7
0.090
Why?
Glucuronosyltransferase
1
2010
4
0.090
Why?
Hyaluronan Synthases
1
2010
5
0.090
Why?
Transforming Growth Factor beta1
1
2010
20
0.090
Why?
Interleukin-1beta
1
2010
51
0.090
Why?
Age Distribution
1
2010
84
0.090
Why?
Sex Distribution
1
2010
75
0.090
Why?
Data Collection
1
1990
93
0.090
Why?
Protein Kinase Inhibitors
1
2010
45
0.090
Why?
RNA, Neoplasm
5
1999
10
0.090
Why?
Hyperplasia
2
2000
17
0.080
Why?
Mice, Inbred A
2
2000
2
0.080
Why?
Cell Line, Tumor
1
2010
221
0.080
Why?
Quality of Life
1
2014
600
0.080
Why?
Disease Progression
4
2008
664
0.080
Why?
Neoplasm Recurrence, Local
2
2006
198
0.080
Why?
Phenotype
1
2010
292
0.080
Why?
Tissue Distribution
9
1998
32
0.080
Why?
Prospective Studies
6
2008
1633
0.080
Why?
DNA, Neoplasm
4
1998
18
0.080
Why?
Prevalence
1
2010
435
0.080
Why?
Gastrins
3
1993
4
0.080
Why?
Time Factors
5
2000
1336
0.080
Why?
Immunoglobulin G
3
1999
92
0.080
Why?
Gene Deletion
2
2000
36
0.080
Why?
Liver Neoplasms
3
1990
93
0.080
Why?
Radionuclide Imaging
7
1991
38
0.070
Why?
5-Lipoxygenase-Activating Proteins
2
1999
2
0.070
Why?
Drug Therapy, Computer-Assisted
1
2007
4
0.070
Why?
Gene Targeting
1
2007
8
0.070
Why?
Patient Selection
2
2014
170
0.070
Why?
Mixed Function Oxygenases
3
1999
4
0.070
Why?
Radiology Information Systems
1
2007
2
0.070
Why?
United States Food and Drug Administration
1
2007
22
0.070
Why?
Regression Analysis
1
1988
255
0.070
Why?
Medical Laboratory Science
1
2007
7
0.070
Why?
Prostatic Neoplasms
2
1999
97
0.070
Why?
Models, Biological
3
2004
311
0.070
Why?
Masoprocol
2
1998
6
0.070
Why?
Carcinogens
2
2000
10
0.070
Why?
Radiography
1
2009
574
0.070
Why?
Genes, p53
2
2000
16
0.070
Why?
Age Factors
4
2012
716
0.070
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
2
0.070
Why?
Diagnosis, Differential
3
2006
341
0.070
Why?
Europe
1
2006
64
0.070
Why?
Iodine Radioisotopes
3
1993
13
0.060
Why?
Culture Media, Conditioned
3
2000
17
0.060
Why?
Cell Line
12
1992
268
0.060
Why?
Bronchoalveolar Lavage
2
2003
2
0.060
Why?
Ligases
2
2003
10
0.060
Why?
HeLa Cells
2
2003
39
0.060
Why?
Patient Care Planning
1
2005
45
0.060
Why?
Apudoma
1
1984
1
0.060
Why?
Angiomatosis
1
1984
3
0.060
Why?
Pheochromocytoma
1
1984
7
0.060
Why?
von Hippel-Lindau Disease
1
1984
6
0.060
Why?
Liver
3
2000
144
0.060
Why?
Spectrum Analysis
1
2004
8
0.060
Why?
Mouth Mucosa
1
2004
12
0.060
Why?
Mouth Neoplasms
1
2004
20
0.060
Why?
Mouthwashes
1
2004
6
0.060
Why?
Cell Proliferation
1
2005
167
0.060
Why?
Placebos
1
2004
68
0.060
Why?
Proteins
2
1996
52
0.060
Why?
Protein Precursors
5
1996
15
0.060
Why?
Cytodiagnosis
2
1993
17
0.060
Why?
Rats
5
2000
649
0.060
Why?
Administration, Inhalation
2
2000
34
0.060
Why?
Endpoint Determination
1
2003
21
0.050
Why?
Dinoprostone
2
2000
16
0.050
Why?
Neovascularization, Pathologic
1
2003
32
0.050
Why?
Immunotherapy
3
2016
53
0.050
Why?
Hypoxia-Inducible Factor 1
1
2003
1
0.050
Why?
Artificial Intelligence
1
2023
31
0.050
Why?
NF-kappa B
1
2003
96
0.050
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2003
10
0.050
Why?
Double-Blind Method
1
2004
396
0.050
Why?
Oxidative Stress
1
2003
93
0.050
Why?
Indium
3
1987
7
0.050
Why?
Enzyme Induction
2
2000
18
0.050
Why?
Somatomedins
2
1996
4
0.050
Why?
Radioisotopes
3
1987
12
0.050
Why?
Amides
3
1998
16
0.050
Why?
Anti-Inflammatory Agents
1
2003
75
0.050
Why?
International Cooperation
1
2002
22
0.050
Why?
Culture Media
2
1996
29
0.050
Why?
Neoplasm Transplantation
3
1998
12
0.050
Why?
Etoposide
5
1996
25
0.050
Why?
Canada
2
2012
48
0.050
Why?
Cisplatin
5
1996
49
0.050
Why?
Survival Analysis
5
2010
246
0.050
Why?
Proteomics
1
2002
85
0.050
Why?
Population Surveillance
2
2012
103
0.050
Why?
bcl-2-Associated X Protein
1
2001
13
0.050
Why?
Societies, Medical
2
2013
138
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2001
18
0.050
Why?
Pulmonary Surfactants
2
1992
4
0.050
Why?
Proteolipids
2
1992
5
0.050
Why?
Respiratory System
2
1992
7
0.050
Why?
Ligands
1
2001
37
0.050
Why?
Rats, Sprague-Dawley
2
2000
322
0.050
Why?
Tumor Stem Cell Assay
4
1999
4
0.050
Why?
Proto-Oncogene Proteins
1
2001
31
0.050
Why?
Public Health
1
2001
66
0.050
Why?
Biopsy
3
2012
199
0.050
Why?
Predictive Value of Tests
3
1997
443
0.050
Why?
Ribonucleoproteins
1
2000
3
0.050
Why?
Binding Sites
2
1993
65
0.050
Why?
Immunologic Tests
1
2000
3
0.050
Why?
Drug Evaluation
3
1990
19
0.050
Why?
Methylation
1
2000
7
0.050
Why?
Loss of Heterozygosity
1
2000
5
0.050
Why?
Comorbidity
2
2012
457
0.040
Why?
HL-60 Cells
1
2000
8
0.040
Why?
Receptors, Interleukin-6
1
2000
3
0.040
Why?
Paracrine Communication
1
2000
4
0.040
Why?
Clinical Trials, Phase II as Topic
1
2000
17
0.040
Why?
Tetradecanoylphorbol Acetate
1
2000
35
0.040
Why?
Interleukin-8
1
2000
17
0.040
Why?
Trans-Activators
1
2000
23
0.040
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2000
16
0.040
Why?
Particle Size
1
2000
48
0.040
Why?
STAT3 Transcription Factor
1
2000
15
0.040
Why?
Interleukin-1
1
2000
48
0.040
Why?
Antibodies
1
2000
48
0.040
Why?
Receptors, Neurotransmitter
2
1991
5
0.040
Why?
RNA, Heterogeneous Nuclear
1
1999
1
0.040
Why?
Fetus
2
1998
37
0.040
Why?
Dogs
2
1991
176
0.040
Why?
Cyclooxygenase 1
1
1999
6
0.040
Why?
Injections, Subcutaneous
2
1991
24
0.040
Why?
Arachidonate 12-Lipoxygenase
1
1999
3
0.040
Why?
Cyclooxygenase 2
1
1999
26
0.040
Why?
Cyclooxygenase 2 Inhibitors
1
1999
19
0.040
Why?
Autocrine Communication
1
1999
2
0.040
Why?
Cinnamates
1
1999
8
0.040
Why?
Pilot Projects
1
2000
392
0.040
Why?
Gene Expression Regulation
1
2000
262
0.040
Why?
CD5 Antigens
1
1998
1
0.040
Why?
Immunoconjugates
1
1998
6
0.040
Why?
Lymphoma, T-Cell, Cutaneous
1
1998
5
0.040
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1998
14
0.040
Why?
Yttrium Radioisotopes
1
1998
10
0.040
Why?
Capillaries
1
1998
11
0.040
Why?
Mammals
1
1998
18
0.040
Why?
Pregnancy
2
1998
291
0.040
Why?
Colonic Neoplasms
1
1999
56
0.040
Why?
Pyridines
1
1998
36
0.040
Why?
Lipoxygenase
1
1998
1
0.040
Why?
Benzoquinones
1
1998
2
0.040
Why?
Quinolines
1
1998
7
0.040
Why?
Bronchi
1
1998
12
0.040
Why?
Insulin-Like Growth Factor II
2
1996
5
0.040
Why?
Lung Diseases
1
1998
42
0.040
Why?
Stimulation, Chemical
2
2000
8
0.040
Why?
Cell Differentiation
4
1992
127
0.040
Why?
Antigens, Surface
4
1986
12
0.040
Why?
Remission Induction
3
1996
80
0.040
Why?
beta Carotene
1
1997
13
0.040
Why?
Physician-Patient Relations
1
2017
37
0.040
Why?
History, 21st Century
1
2017
18
0.040
Why?
Nurse-Patient Relations
1
2017
57
0.040
Why?
Follow-Up Studies
3
2006
1689
0.040
Why?
Positron-Emission Tomography
2
2008
84
0.030
Why?
Liver Function Tests
2
1988
19
0.030
Why?
Drug Resistance
3
1994
37
0.030
Why?
In Vitro Techniques
3
1992
157
0.030
Why?
Tomography, Emission-Computed
1
1996
9
0.030
Why?
Diet
2
2000
207
0.030
Why?
Communication
1
2017
119
0.030
Why?
Peptide Fragments
2
1996
71
0.030
Why?
Aminopterin
1
1996
1
0.030
Why?
Folic Acid Antagonists
1
1996
1
0.030
Why?
Dipyridamole
1
1996
2
0.030
Why?
Computer Communication Networks
1
1996
3
0.030
Why?
Maryland
1
1996
7
0.030
Why?
Receptor, IGF Type 1
1
1996
19
0.030
Why?
Decision Making
1
2017
203
0.030
Why?
Molecular Biology
2
2007
11
0.030
Why?
Gene Expression
1
1996
182
0.030
Why?
Drug Resistance, Neoplasm
1
1996
57
0.030
Why?
Statistics, Nonparametric
2
2008
119
0.030
Why?
Antigens, Differentiation
1
1994
9
0.030
Why?
Cell Membrane
2
1993
85
0.030
Why?
Receptors, Estrogen
2
2005
56
0.030
Why?
Tumor Suppressor Protein p53
1
1994
75
0.030
Why?
Fluorodeoxyglucose F18
2
2008
36
0.030
Why?
Atrial Natriuretic Factor
1
1993
2
0.030
Why?
Arginine Vasopressin
1
1993
2
0.030
Why?
Inositol
1
1993
6
0.030
Why?
Environmental Exposure
1
1993
17
0.030
Why?
Mitogens
1
1992
5
0.030
Why?
Sodium
1
1993
61
0.030
Why?
Severity of Illness Index
1
2016
913
0.030
Why?
Uteroglobin
1
1992
1
0.020
Why?
Amidine-Lyases
1
1991
1
0.020
Why?
Chromogranins
2
1988
3
0.020
Why?
Hormones
1
1991
9
0.020
Why?
Gastric Acid
1
1991
7
0.020
Why?
Tamoxifen
1
1992
26
0.020
Why?
Treatment Outcome
4
2006
3231
0.020
Why?
Antigens, Tumor-Associated, Carbohydrate
1
1991
1
0.020
Why?
Chromosome Aberrations
1
1991
9
0.020
Why?
Retrospective Studies
2
1992
3220
0.020
Why?
Tretinoin
1
1991
13
0.020
Why?
Chromosome Disorders
1
1991
10
0.020
Why?
Cluster Analysis
1
1991
39
0.020
Why?
Palliative Care
2
1996
99
0.020
Why?
Adenoma
1
1992
56
0.020
Why?
Injections
1
1991
43
0.020
Why?
Blotting, Western
3
1996
140
0.020
Why?
Carboplatin
1
1990
20
0.020
Why?
Insulin
2
1988
83
0.020
Why?
Up-Regulation
2
2001
150
0.020
Why?
Chromosome Deletion
2
1990
14
0.020
Why?
Glycosphingolipids
1
1989
1
0.020
Why?
Tumor Burden
1
2010
25
0.020
Why?
Confidence Intervals
1
2010
85
0.020
Why?
SEER Program
1
2010
37
0.020
Why?
Glycolipids
2
1986
2
0.020
Why?
Models, Statistical
1
2010
120
0.020
Why?
Epidermal Growth Factor
1
1989
27
0.020
Why?
Mating Factor
1
1989
1
0.020
Why?
Chemistry
1
1989
2
0.020
Why?
Chemical Phenomena
1
1989
4
0.020
Why?
Saccharomyces cerevisiae
1
1989
17
0.020
Why?
Registries
1
2010
170
0.020
Why?
Glutaral
1
1988
1
0.020
Why?
Polyvinyl Chloride
1
1988
1
0.020
Why?
Fixatives
1
1988
5
0.020
Why?
Aromatic-L-Amino-Acid Decarboxylases
1
1988
1
0.020
Why?
Dopa Decarboxylase
1
1988
1
0.020
Why?
Cytoplasmic Granules
1
1988
3
0.020
Why?
Neurosecretory Systems
1
1988
9
0.020
Why?
Random Allocation
1
1988
116
0.020
Why?
Tetrazolium Salts
1
1988
2
0.020
Why?
Spectrophotometry
1
1988
4
0.020
Why?
Selenium
1
1988
9
0.020
Why?
Thiazoles
1
1988
19
0.020
Why?
Models, Theoretical
1
1988
76
0.020
Why?
Antibody Formation
1
1988
16
0.020
Why?
Estradiol
1
1988
33
0.020
Why?
Hydrocortisone
1
1988
35
0.020
Why?
Radiopharmaceuticals
1
2008
48
0.020
Why?
Chi-Square Distribution
1
2008
126
0.020
Why?
Contrast Media
1
2008
68
0.020
Why?
Databases, Protein
1
2007
1
0.020
Why?
Databases as Topic
1
2007
14
0.020
Why?
Histocompatibility Antigens Class II
1
1987
6
0.020
Why?
Nerve Tissue Proteins
1
1988
140
0.020
Why?
Bronchoscopy
1
1987
24
0.020
Why?
Spleen
1
1987
32
0.020
Why?
Research Design
1
1988
188
0.020
Why?
Chromatography, High Pressure Liquid
2
1996
13
0.020
Why?
Vincristine
2
1996
17
0.020
Why?
Gene Amplification
1
1986
18
0.020
Why?
Cyclophosphamide
2
1996
43
0.020
Why?
Electrophoresis, Polyacrylamide Gel
2
1996
26
0.020
Why?
Doxorubicin
2
1996
47
0.020
Why?
Methotrexate
2
1996
34
0.020
Why?
beta 2-Microglobulin
1
1985
1
0.020
Why?
Avidin
1
1985
1
0.020
Why?
Ovalbumin
1
1985
6
0.020
Why?
Biotin
1
1985
7
0.020
Why?
HLA Antigens
1
1985
16
0.020
Why?
Ki-67 Antigen
1
2005
15
0.020
Why?
Pedigree
1
1984
48
0.010
Why?
Stromal Cells
1
2005
28
0.010
Why?
Lewis X Antigen
1
1984
1
0.010
Why?
Genes, Dominant
1
1984
10
0.010
Why?
Receptors, Bombesin
3
1991
3
0.010
Why?
Oligosaccharides
1
1984
15
0.010
Why?
Sulfur
1
1984
2
0.010
Why?
Technetium Tc 99m Sulfur Colloid
1
1984
5
0.010
Why?
Technetium
1
1984
4
0.010
Why?
Cell Survival
2
1998
110
0.010
Why?
Scattering, Radiation
1
2004
36
0.010
Why?
Microscopy, Electron
2
1998
61
0.010
Why?
Monte Carlo Method
1
2004
52
0.010
Why?
Carcinoma, Bronchogenic
1
1984
4
0.010
Why?
Binding Sites, Antibody
1
1983
2
0.010
Why?
Antigen-Antibody Reactions
1
1983
5
0.010
Why?
Computer Simulation
1
2004
183
0.010
Why?
Immunoblotting
2
1996
50
0.010
Why?
Drug Synergism
2
1996
40
0.010
Why?
Brain Neoplasms
2
1996
76
0.010
Why?
Consensus Development Conferences as Topic
1
2002
6
0.010
Why?
Guidelines as Topic
1
2002
61
0.010
Why?
Epitopes
2
1996
44
0.010
Why?
Rabbits
2
1996
184
0.010
Why?
Transcription, Genetic
2
1996
100
0.010
Why?
Pulmonary Surfactant-Associated Proteins
2
1992
2
0.010
Why?
Mice, Inbred SENCAR
1
2000
1
0.010
Why?
Transglutaminases
1
2000
2
0.010
Why?
GTP-Binding Proteins
1
2000
10
0.010
Why?
Analysis of Variance
2
1991
256
0.010
Why?
Receptors, Cell Surface
2
1992
37
0.010
Why?
Ditiocarb
1
1999
1
0.010
Why?
Fatty Acids, Monounsaturated
1
1999
2
0.010
Why?
Hygromycin B
1
1999
2
0.010
Why?
Oligonucleotides, Antisense
1
1999
11
0.010
Why?
Histocytochemistry
2
1992
16
0.010
Why?
Radioimmunotherapy
1
1998
1
0.010
Why?
Transfection
1
1999
112
0.010
Why?
Lymphocyte Subsets
1
1998
7
0.010
Why?
Cell Death
1
1998
40
0.010
Why?
Chromogranin A
2
1988
10
0.010
Why?
Carbohydrate Sequence
2
1989
5
0.010
Why?
Transplantation, Heterologous
2
1990
17
0.010
Why?
Proto-Oncogenes
2
1990
2
0.010
Why?
Tin
1
1997
1
0.010
Why?
Mining
1
1997
3
0.010
Why?
China
1
1997
46
0.010
Why?
Calcium
2
1991
364
0.010
Why?
Deoxyglucose
1
1996
2
0.010
Why?
Fluorine Radioisotopes
1
1996
5
0.010
Why?
Breast
1
1996
22
0.010
Why?
Cyanogen Bromide
1
1996
1
0.010
Why?
Chromatography, Ion Exchange
1
1996
5
0.010
Why?
Peptide Mapping
1
1996
4
0.010
Why?
T-Lymphocytes
2
1987
88
0.010
Why?
Phantoms, Imaging
1
1996
37
0.010
Why?
Anti-Bacterial Agents
1
1999
333
0.010
Why?
Mammography
1
1996
41
0.010
Why?
Cranial Irradiation
1
1996
13
0.010
Why?
Lomustine
1
1996
1
0.010
Why?
Mechlorethamine
1
1996
1
0.010
Why?
Nucleosides
1
1996
2
0.010
Why?
Sequence Analysis
1
1996
3
0.010
Why?
Carmustine
1
1996
2
0.010
Why?
Thymidine
1
1996
6
0.010
Why?
Immune Sera
1
1996
5
0.010
Why?
Depression, Chemical
1
1996
5
0.010
Why?
Sequence Alignment
1
1996
18
0.010
Why?
Cross Reactions
1
1996
10
0.010
Why?
Proteasome Endopeptidase Complex
1
1996
22
0.010
Why?
Biological Transport
1
1996
38
0.010
Why?
Antibody Specificity
1
1996
32
0.010
Why?
Evaluation Studies as Topic
1
1996
36
0.010
Why?
Protein Conformation
1
1996
69
0.010
Why?
Radiotherapy Dosage
1
1996
110
0.010
Why?
Cause of Death
1
1996
63
0.010
Why?
Specimen Handling
1
1996
43
0.010
Why?
Blotting, Southern
1
1995
3
0.010
Why?
Culture Media, Serum-Free
1
1995
6
0.010
Why?
Chromatography, Gel
1
1995
8
0.010
Why?
Homozygote
1
1995
17
0.010
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
1995
17
0.010
Why?
Hemoglobins
1
1996
72
0.010
Why?
Serum Albumin
1
1995
19
0.010
Why?
Triglycerides
1
1995
57
0.010
Why?
Drug Therapy
1
1995
9
0.010
Why?
Antigen-Antibody Complex
2
1985
5
0.010
Why?
Leukopenia
1
1994
5
0.010
Why?
Thrombocytopenia
1
1994
20
0.010
Why?
Proliferating Cell Nuclear Antigen
1
1994
8
0.010
Why?
Drug Administration Schedule
1
1994
152
0.010
Why?
Radiation Tolerance
1
1994
6
0.010
Why?
Adolescent
2
1994
2076
0.010
Why?
Neoplastic Stem Cells
1
1994
6
0.010
Why?
Lymphatic Metastasis
1
1994
81
0.010
Why?
Weight Loss
1
1994
105
0.010
Why?
Ribonucleases
1
1993
7
0.010
Why?
Inappropriate ADH Syndrome
1
1993
2
0.010
Why?
Hyponatremia
1
1993
8
0.010
Why?
Aged, 80 and over
1
2001
4459
0.010
Why?
Infant
1
1994
529
0.010
Why?
Chemotherapy, Adjuvant
1
1992
69
0.010
Why?
Staining and Labeling
1
1992
16
0.010
Why?
Child, Preschool
1
1994
640
0.010
Why?
Lyases
1
1991
7
0.010
Why?
Exons
1
1992
29
0.010
Why?
Infant, Newborn
1
1994
588
0.010
Why?
Glycine
1
1991
12
0.010
Why?
Genetic Testing
1
1992
56
0.010
Why?
Polymorphism, Restriction Fragment Length
1
1991
4
0.010
Why?
Chromosome Banding
1
1991
1
0.010
Why?
Karyotyping
1
1991
8
0.010
Why?
Chromosome Mapping
1
1991
26
0.010
Why?
Pleural Effusion
1
1991
11
0.010
Why?
Alleles
1
1991
190
0.010
Why?
Pulmonary Surfactant-Associated Protein A
1
1990
1
0.010
Why?
DNA Probes
1
1990
7
0.010
Why?
Dexamethasone
1
1990
34
0.010
Why?
Glycoproteins
1
1990
43
0.010
Why?
Hormones, Ectopic
1
1990
1
0.010
Why?
Paraneoplastic Endocrine Syndromes
1
1990
1
0.010
Why?
Antibodies, Neoplasm
1
1990
13
0.010
Why?
Carbohydrate Conformation
1
1989
5
0.010
Why?
Body Fluids
1
1990
13
0.010
Why?
Child
1
1994
1277
0.010
Why?
Carcinoembryonic Antigen
1
1988
4
0.000
Why?
Leucine
1
1988
10
0.000
Why?
Phosphopyruvate Hydratase
1
1988
12
0.000
Why?
Peptide Biosynthesis
1
1988
1
0.000
Why?
Carcinoid Tumor
1
1988
5
0.000
Why?
Type C Phospholipases
1
1988
8
0.000
Why?
Cell Communication
1
1988
20
0.000
Why?
Cytoplasm
1
1988
30
0.000
Why?
Receptor, Insulin
1
1988
1
0.000
Why?
Receptors, Somatomedin
1
1988
4
0.000
Why?
Immunoglobulin Isotypes
1
1987
3
0.000
Why?
Immunization
1
1987
15
0.000
Why?
Immunoglobulin M
1
1987
14
0.000
Why?
Fluorescent Antibody Technique
1
1987
55
0.000
Why?
Whole-Body Counting
1
1987
2
0.000
Why?
Lymphatic System
1
1987
4
0.000
Why?
Drug Carriers
1
1987
7
0.000
Why?
Mycosis Fungoides
1
1987
5
0.000
Why?
P Blood-Group System
1
1986
1
0.000
Why?
Gangliosides
1
1986
6
0.000
Why?
ABO Blood-Group System
1
1986
5
0.000
Why?
Kinetics
1
1987
179
0.000
Why?
Melanoma
1
1987
52
0.000
Why?
Cell Separation
1
1986
28
0.000
Why?
Cell Cycle
1
1986
32
0.000
Why?
Postoperative Complications
1
1992
827
0.000
Why?
Cytogenetics
1
1986
1
0.000
Why?
Flow Cytometry
1
1986
107
0.000
Why?
Binding, Competitive
1
1985
21
0.000
Why?
Genes, MHC Class II
1
1985
1
0.000
Why?
Interferons
1
1985
7
0.000
Why?
HLA-B Antigens
1
1985
8
0.000
Why?
HLA-A Antigens
1
1985
13
0.000
Why?
HLA-C Antigens
1
1985
10
0.000
Why?
Peroxidase
1
1985
15
0.000
Why?
Peroxidases
1
1985
7
0.000
Why?
Rats, Inbred Strains
1
1984
23
0.000
Why?
Aging
1
1992
1429
0.000
Why?
Mulshine's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (641)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_